Todas las investigaciones
ReclutamientoConfirmatorio terapéutico (Fase III)Intervencionista

A pivotal phase 3 clinical trial to assess the diagnostic performance and safety of [68Ga]Ga-PentixaFor ([68Ga]Ga-PTF), a positron emission tomography (PET) imaging agent, versus [18F]FDG PET/CT imaging, for staging of patients with confirmed marginal zone lymphoma (MZL) exemplary for CXCR4-positive malignant lymphomas: a prospective, international, multi-center, comparative, randomized, cross-over, open-label lymphoma diagnostic trial (LYMFOR).

This study is looking at people who have been diagnosed with marginal zone lymphoma, which is a type of cancer. It compares two different types of body scans, called PET/CT scans. One scan uses a substance called [68Ga]Ga-PentixaFor, and the other uses [18F]FDG. The main goal is to find out if the [68Ga]Ga-PentixaFor scan is better, or at least as good as, the standard [18F]FDG scan at spotting cancer cells in the body. Researchers also want to see if these scans help doctors plan the best treatment for patients and how different doctors interpret the scan results. This information will help improve how this cancer is diagnosed and managed.

De un vistazo

Estado
Reclutamiento
Fase
Confirmatorio terapéutico (Fase III)
Patrocinador
Pentixapharm AG
Objetivo de inscripción
148
Inicio
29 Nov 2023

¿De qué trata este estudio?

This study is about a type of cancer called marginal zone lymphoma. When someone is diagnosed with cancer, doctors need to know if the cancer has spread and how much. This process is called "staging," and it helps doctors decide on the best treatment plan. Currently, a type of scan called an [18F]FDG PET/CT scan is often used for this purpose.

This study is comparing that standard [18F]FDG PET/CT scan with a newer type of scan called a [68Ga]Ga-PentixaFor PET/CT scan. Both are types of body scans that can help doctors see inside the body. The researchers want to find out if the newer [68Ga]Ga-PentixaFor scan is better or at least as good as the standard scan at finding cancer cells. They are particularly interested in seeing if it can find cancer cells more accurately.

The study will also look at how reliable each scan is, meaning whether different doctors get the same results when looking at the scans. Importantly, they want to see if the information from either scan changes how doctors decide to treat a patient. By comparing these two scans, the study hopes to improve the way marginal zone lymphoma is diagnosed and to help doctors make more informed decisions about treatment.

Puntos clave

  • A study for people with marginal zone lymphoma.
  • Compares two types of body scans (PET/CT) to find cancer more effectively.
  • Aims to see if a newer scan is better than the standard one.
  • Hopes to improve how marginal zone lymphoma is diagnosed and managed.
  • Participation involves having two different diagnostic scans and follow-up.

¿Quién puede ser elegible?

To be considered for this study, you must be at least 18 years old. Both men and women can take part.

Key to joining is having a confirmed diagnosis of marginal zone lymphoma. This means your doctors have already found that you have this specific type of cancer.

The study welcomes people of all ages who meet the basic requirements, but there will be specific medical checks to ensure it's safe for you to participate.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tienes 18 años o más?
  2. Have you been diagnosed with marginal zone lymphoma?
  3. Are you able to travel to the study site for appointments?
  4. Are you comfortable having two different types of body scans?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you join this study, you will have two different types of PET/CT body scans. These scans will be done at different times, in no particular order. You will also have follow-up appointments where doctors will check your progress and review your medical information and scan results. The exact number of visits and the total length of your participation will be explained in detail by the study team, but it includes the scans and ongoing monitoring of your condition.

Riesgos y beneficios potenciales

Taking part in this study could offer the benefit of receiving advanced diagnostic imaging that might provide more detailed information about your condition. You would also be contributing to medical knowledge that could help future patients with marginal zone lymphoma. Potential risks include those normally associated with PET/CT scans, such as exposure to small amounts of radiation and possible allergic reactions to the substances used in the scans. As with any study, you are free to withdraw at any time without affecting your medical care.

Ubicaciones (5)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Alemania
  • —
    No verificado
    Italia
  • —
    No verificado
    España
  • —
    No verificado
    Francia
  • —
    No verificado
    Austria

Preguntas comunes

What is marginal zone lymphoma?

Marginal zone lymphoma is a type of cancer that affects a certain kind of white blood cell called lymphocytes. It's generally a slow-growing cancer.

What is a PET/CT scan?

A PET/CT scan is a special imaging test that combines two types of scans. It helps doctors see how well your body's cells are working and can pinpoint areas of disease, like cancer.

What's the difference between the two scans being compared?

Both are PET/CT scans, but they use slightly different substances (called 'tracers') to highlight areas in your body. The study wants to see if one tracer is better at finding marginal zone lymphoma cells than the other.

Will my treatment change if I join the study?

The study aims to see if these scans *impact* treatment planning, but your actual treatment decisions will always be made by your doctor based on all available information, including your study results.

Do I have to pay to be in the study?

No, you do not have to pay to participate in a clinical trial. All study-related procedures and scans will be covered.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A pivotal phase 3 clinical trial to assess the diagnostic pe…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.